$PBSV SEC Filings

Filed On	Filing
14 Sep 2026	8-K: Results of Operations and Financial Condition DORADO, PR / ACCESS Newswire / September 14, 2026 / Pharma-Bio Serv, Inc. (“Pharma-Bio Serv” or the “Company”) (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues f...
14 Sep 2026	FORM 10-Q
22 Jul 2026	Form 4: Spindel Howard, Director Disposed of 42,504 shares (Other Transaction)
15 Jun 2026	8-K: Results of Operations and Financial Condition
15 Jun 2026	FORM 10-Q
15 May 2026	8-K: Submission of Matters to a Vote of Security Holders
16 Apr 2026	ARS
16 Apr 2026	Proxy statement: annual meeting on May 15, 2026
17 Mar 2026	8-K: Results of Operations and Financial Condition
17 Mar 2026	FORM 10-Q
27 Feb 2026	FORM 10-K/A
29 Jan 2026	8-K: Results of Operations and Financial Condition
29 Jan 2026	FORM 10-K
14 Jan 2026	Form 4: Michel Kirk Wheeler, Director Granted 20,000 Stock Option
14 Jan 2026	Form 4: Perlysky Dov, Director Granted 20,000 Stock Option
14 Jan 2026	Form 4: Spindel Howard, Director Granted 20,000 Stock Option
14 Jan 2026	Form 4: Wiesen Irving L, Director Granted 20,000 Stock Option
15 Sep 2025	8-K: Results of Operations and Financial Condition
15 Sep 2025	FORM 10-Q
16 Jun 2025	FORM 10-Q

Comments